Natco Pharma Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Sep '24
Jun '24
Mar '24
Dec '23
Sep '23
Total Qtr Revenue cr
1,434.90
1,410.70
1,110.30
795.60
1,060.80
Other Income Qtr Cr63.8048.1042.0037.0029.40
Operating Revenues Qtr1,371.101,362.601,068.30758.601,031.40

*All values are in Cr.

Operating Expenses Qtr
566.80
557.80
571.00
490.50
573.40
Operating Profit Qtr
804.30
804.80
497.30
268.10
458.00
EBIDT Qtr Cr
868.10
852.90
539.30
305.10
487.40
Depreciation Qtr
45.80
44.10
55.50
44.20
43.60
Net Profit Qtr
677.30
668.50
386.30
212.70
369.00
Basic EPS Qtr
37.81
37.32
21.56
11.88
20.60
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -